ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 265 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $170,000 | -28.0% | 12,730 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $236,000 | +23.6% | 12,730 | 0.0% | 0.01% | +28.6% |
| Q1 2021 | $191,000 | +3.8% | 12,730 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $184,000 | +76.9% | 12,730 | 0.0% | 0.01% | +40.0% |
| Q3 2020 | $104,000 | +20.9% | 12,730 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $86,000 | -4.4% | 12,730 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $90,000 | -28.0% | 12,730 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $125,000 | -10.7% | 12,730 | 0.0% | 0.01% | -14.3% |
| Q3 2019 | $140,000 | -5.4% | 12,730 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $148,000 | +21.3% | 12,730 | -0.1% | 0.01% | +16.7% |
| Q1 2019 | $122,000 | -0.8% | 12,745 | +0.1% | 0.01% | -14.3% |
| Q4 2018 | $123,000 | -32.0% | 12,730 | 0.0% | 0.01% | -22.2% |
| Q3 2018 | $181,000 | +18.3% | 12,730 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $153,000 | -2.5% | 12,730 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $157,000 | -15.6% | 12,730 | -0.4% | 0.01% | -9.1% |
| Q4 2017 | $186,000 | -73.0% | 12,785 | -73.6% | 0.01% | -79.2% |
| Q3 2017 | $689,000 | +11.5% | 48,445 | 0.0% | 0.05% | +6.0% |
| Q2 2017 | $618,000 | +0.7% | 48,445 | 0.0% | 0.05% | +6.4% |
| Q1 2017 | $614,000 | +24.0% | 48,445 | 0.0% | 0.05% | +11.9% |
| Q4 2016 | $495,000 | -22.4% | 48,445 | 0.0% | 0.04% | -44.0% |
| Q3 2016 | $638,000 | +3.7% | 48,445 | 0.0% | 0.08% | +5.6% |
| Q2 2016 | $615,000 | -3.9% | 48,445 | 0.0% | 0.07% | +1.4% |
| Q1 2016 | $640,000 | -14.1% | 48,445 | 0.0% | 0.07% | -12.5% |
| Q4 2015 | $745,000 | +24.0% | 48,445 | 0.0% | 0.08% | +23.1% |
| Q3 2015 | $601,000 | -9.4% | 48,445 | 0.0% | 0.06% | +3.2% |
| Q2 2015 | $663,000 | +14.5% | 48,445 | 0.0% | 0.06% | +26.0% |
| Q1 2015 | $579,000 | -6.5% | 48,445 | 0.0% | 0.05% | -10.7% |
| Q4 2014 | $619,000 | -2.7% | 48,445 | +22.3% | 0.06% | +5.7% |
| Q2 2014 | $636,000 | +3.9% | 39,600 | 0.0% | 0.05% | -14.5% |
| Q4 2013 | $612,000 | +3.9% | 39,600 | 0.0% | 0.06% | 0.0% |
| Q3 2013 | $589,000 | +14.8% | 39,600 | 0.0% | 0.06% | +1.6% |
| Q2 2013 | $513,000 | – | 39,600 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 10,507,149 | $138,799,000 | 8.42% |
| Tamarack Advisers, LP | 1,650,000 | $21,797,000 | 7.63% |
| Blue Harbour Group | 10,759,695 | $142,136,000 | 4.78% |
| BROADVIEW ADVISORS LLC | 1,095,800 | $14,476,000 | 2.08% |
| Rovida Advisors Inc. | 752,400 | $9,939,000 | 2.04% |
| Adirondack Research & Management Inc. | 361,259 | $4,772,000 | 1.73% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,104,400 | $14,589,000 | 1.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 14,401,161 | $190,239,000 | 1.62% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5,077,304 | $67,071,000 | 1.30% |
| Iguana Healthcare Management, LLC | 250,000 | $3,303,000 | 1.21% |